SEGMENT INFORMATION (Tables)

3 Months Ended

Mar. 31, 2025

Segment Reporting [Abstract]

Schedule of Significant Segment Information

Pursuant to ASU 2023-07, "Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures", the significant segment information is summarized as follows:

	For the Three Months Ended March 31, 2025
	HNH			ANH			SP			Other and Unallocated			Total
Net sales	$	158,457		$	57,277		$	33,275		$	1,510		$	250,519
Cost of sales	99,383		(1)	44,917		(1)	15,986		(1)	2,065		(1)	162,351
Gross margin	59,074			12,360			17,289			(555)			88,168
Operating expenses	21,100		(2)	7,124		(3)	7,704		(4)	1,225		(5)	37,153
Earnings from operations	37,974			5,236			9,585			(1,780)			51,015
Other expenses:
Interest expense, net													2,924
Other expense													151
													3,075
Earnings before income    tax expense													47,940
Income tax expense													10,887
Net earnings													$	37,053

(1) Cost of sales are primarily comprised of raw materials consumed in the manufacture of product, as well as manufacturing labor, depreciation expense, and other overhead expenses necessary to convert purchased materials and supplies into finished product. Cost of sales also includes inbound freight costs, outbound freight costs for shipping products to customers, warehousing costs, quality control and obsolescence expense.

(2) Operating expenses within HNH are primarily comprised of compensation-related costs, professional services, including advertising and marketing costs, and amortization expense in connection with certain acquired intangible assets.

(3) Operating expenses within ANH are primarily comprised of compensation-related costs and professional services, including advertising and marketing costs.

(4) Operating expenses within SP are primarily comprised of compensation-related costs, professional services, and amortization expense in connection with certain acquired intangible assets.

(5) Operating expenses within Other and Unallocated are primarily comprised of transaction and integration costs.

	For the Three Months Ended March 31, 2024
	HNH			ANH			SP			Other and Unallocated			Total
Net sales	$	152,744		$	53,921		$	31,613		$	1,381		$	239,659
Cost of sales	97,382		(6)	44,235		(6)	14,624		(6)	1,904		(6)	158,145
Gross margin	55,362			9,686			16,989			(523)			81,514
Operating expenses	22,105		(7)	7,626		(8)	8,790		(9)	1,317		(10)	39,838
Earnings from operations	33,257			2,060			8,199			(1,840)			41,676
Other expenses:
Interest expense, net													5,398
Other income													(572)
													4,826
Earnings before income    tax expense													36,850
Income tax expense													7,864
Net earnings													$	28,986

(6) Cost of sales are primarily comprised of raw materials consumed in the manufacture of product, as well as manufacturing labor, depreciation expense, and other overhead expenses necessary to convert purchased materials and supplies into finished product. Cost of sales also includes inbound freight costs, outbound freight costs for shipping products to customers, warehousing costs, quality control and obsolescence expense.

(7) Operating expenses within HNH are primarily comprised of compensation-related costs, professional services, including advertising and marketing costs, and amortization expense in connection with certain acquired intangible assets.

(8) Operating expenses within ANH are primarily comprised of compensation-related costs and professional services, including advertising and marketing costs.

(9) Operating expenses within SP are primarily comprised of compensation-related costs, professional services, and amortization expense in connection with certain acquired intangible assets.

(10) Operating expenses within Other and Unallocated are primarily comprised of transaction and integration costs.

Business Segment Assets	March 31, 2025		December 31, 2024
Human Nutrition and Health	$	1,213,407	$	1,185,962
Animal Nutrition and Health	169,464		161,243
Specialty Products	166,745		161,283
Other and Unallocated (11)	67,939		66,883
Total	$	1,617,555	$	1,575,371

(11) Other and Unallocated assets consist of certain cash, capitalized loan issuance costs, other assets, investments, and income taxes, which the Company does not allocate to its individual business segments. It also includes assets associated with a few minor businesses which individually do not meet the quantitative thresholds for separate presentation.

Depreciation/Amortization	Three Months Ended March 31,
	2025		2024
Human Nutrition and Health	$	7,303	$	9,540
Animal Nutrition and Health	1,761		2,102
Specialty Products	1,726		1,779
Other and Unallocated	224		247
Total	$	11,014	$	13,668

Capital Expenditures	Three Months Ended March 31,
	2025		2024
Human Nutrition and Health	$	2,327	$	4,260
Animal Nutrition and Health	2,344		2,021
Specialty Products	722		435
Other and Unallocated	28		70
Total	$	5,421	$	6,786